{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06137807",
            "orgStudyIdInfo": {
                "id": "CTP-TRIC-005"
            },
            "organization": {
                "fullName": "P+F Products + Features USA Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "TRIcvalve biCAVal Valve System for Severe Tricuspid Regurgitation (TRICAV)",
            "officialTitle": "A Prospective, Multicenter Clinical Trial of the TricValve\u00ae Transcatheter Bicaval Valve System in Subjects With Severe Tricuspid Regurgitation - TRICAV Trial",
            "acronym": "TRICAV",
            "therapeuticArea": [
                "Critical Care"
            ],
            "study": "tricvalve-bicaval-valve-system-for-severe-tricuspid-regurgitation-tricav"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "NOT_YET_RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-07",
                "type": "ESTIMATED"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2029-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-31",
            "studyFirstSubmitQcDate": "2023-11-14",
            "studyFirstPostDateStruct": {
                "date": "2023-11-18",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-01",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-03",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "P+F Products + Features USA Inc.",
                "class": "INDUSTRY"
            },
            "collaborators": [
                {
                    "name": "P+F Products + Features GmbH",
                    "class": "INDUSTRY"
                },
                {
                    "name": "Meditrial USA Inc.",
                    "class": "INDUSTRY"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": true,
            "isUnapprovedDevice": true
        },
        "descriptionModule": {
            "briefSummary": "The TricValve\u00ae Transcatheter Bicaval Valve System is a bicaval transcatheter tricuspid valve replacement system, which includes the TricValve\u00ae Transcatheter Bicaval Valve for superior vena cava (SVC) and the TricValve\u00ae Transcatheter Bicaval Valve for inferior vena cava (IVC). The TricValve\u00ae Transcatheter Bicaval Valves are pre-mounted into the TricValve\u00ae Delivery System which is used for percutaneous access and delivery of the TricValve\u00ae Transcatheter Bicaval Valve in the vena cava. The system is a single use, sterile device compatible with all the valve sizes. The prostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. The device is made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system.",
            "detailedDescription": "This is a prospective multicenter clinical investigation designed to evaluate the safety and effectiveness of the TricValve\u00ae Transcatheter Bicaval Valve System for improving outcomes in symptomatic subjects with severe TR deemed by the local Heart Team to be at high risk for tricuspid valve surgery.\n\nPatients who meet all of the study inclusion criteria, will be treated with the TricValve System. After the intervention, patients will be followed up closely for 12 months. Long term safety and efficacy data will be collected annually up to 5 years."
        },
        "conditionsModule": {
            "conditions": [
                "Tricuspid Regurgitation",
                "Tricuspid Valve Disease"
            ],
            "keywords": [
                "Tricuspid Regurgitation",
                "Heart Failure"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "NA"
            ],
            "designInfo": {
                "allocation": "NA",
                "interventionModel": "SINGLE_GROUP",
                "interventionModelDescription": "Prospective, multicenter clinical trial. Subjects will be selected by their local Heart Team to be at high risk and deemed eligible by an independent eligibility committee (IEC).",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 15,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "TricValve\u00ae Device (Device) Group",
                    "type": "EXPERIMENTAL",
                    "description": "subjects will undergo TricValve\u00ae implantation and will continue to be managed with optimal medical therapies, per physician discretion.",
                    "interventionNames": [
                        "Device: TricValve\u00ae Transcatheter Bicaval Valve System"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DEVICE",
                    "name": "TricValve\u00ae Transcatheter Bicaval Valve System",
                    "description": "The TricValve\u00ae Transcatheter Bicaval Valve System is a bicaval transcatheter tricuspid valve replacement system, which includes the TricValve\u00ae Transcatheter Bicaval Valve for superior vena cava (SVC) and the TricValve\u00ae Transcatheter Bicaval Valve for inferior vena cava (IVC). The system is a single use, sterile device compatible with all the valve sizes. The valves are premounted in the TricValve\u00ae Delivery System. The prostheses are implanted percutaneously into the inferior and superior vena cava without disturbing the native tricuspid valve. The device is made of bovine pericardium leaflets sutured on a nitinol self-expanding stent system available in sizes 25 and 29 for superior vena cava and 31 and 35 for inferior vena cava. The valve is implanted percutaneously by the transfemoral approach. The valves are supplied already premounted into the TricValve\u00ae Delivery System.",
                    "armGroupLabels": [
                        "TricValve\u00ae Device (Device) Group"
                    ],
                    "otherNames": [
                        "TricValve System"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Mortality",
                    "description": "Number of days until death",
                    "timeFrame": "1 Month and 12 Months"
                },
                {
                    "measure": "Stroke",
                    "description": "Number of days until death",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Pulmonary Embolism",
                    "description": "Number of days until death",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Valve Academic Research Consortium (VARC) type 2-4 bleeding complication",
                    "description": "Number of days until death",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Major vascular, access-related, or cardiac structural complication",
                    "description": "Number of days until death",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Stage 3 Acute Kidney Injury with increase in serum creatinine >300% (>3.0x increase) and/or serum creatinine \u22654.0mg/dL (\u2265354 \u03bcmol/L) with an acute increase of \u2265 0.5 mg/dL (\u226544 \u03bcmol/L)",
                    "description": "Number of days from baseline until increase",
                    "timeFrame": "7 Days"
                },
                {
                    "measure": "Stage 4 Acute Kidney Injury requiring new temporary or permanent renal replacement therapy",
                    "description": "Number of days until new renal replacement therapy",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Emergency surgery or intervention related to the device/procedure complications",
                    "description": "Number of days until emergency surgery or intervention",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Right Ventricular Assist Device (RVAD) implantation or heart transplant",
                    "description": "Number of days until Right Ventricular Assist Device (RVAD) implantation or heart transplant",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Tricuspid valve surgery or percutaneous tricuspid intervention",
                    "description": "Number of days until tricuspid valve surgery or percutaneous tricuspid intervention",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Heart Failure Events",
                    "description": "Number of heart failure episodes including hospitalization, or worsening heart failure",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Kansas City Cardiomyopathy Questionnaire (KCCQ) Score",
                    "description": "Change in KCC score (score ranges between 0 and 100)",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "New York Heart Association (NYHA class)",
                    "description": "Change in NYHA class (range from I to IV)",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Six Minute Walking Test (6MWT)",
                    "description": "Change in walking distance",
                    "timeFrame": "12 Months"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Technical success of device placement (at exit from procedure room)",
                    "description": "* Freedom from mortality\n* Successful access, delivery of the device, and retrieval of the delivery system\n* Correct positioning of the device into the proper anatomical location\n* Freedom from surgery or intervention related to the device or to a major vascular or access-related, or cardiac structural complication",
                    "timeFrame": "Intraprocedural"
                },
                {
                    "measure": "Device success within 30 days after device placement",
                    "description": "* Technical success\n* Freedom from mortality\n* Freedom from surgery or intervention related to the device or to a major vascular or access-related or cardiac structural complication",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Procedural success (at 30 days)",
                    "description": "All of the following criteria must be met to be considered a procedural success:\n\n* Device success (defined above), and\n* Absence of major device or procedure related serious adverse events",
                    "timeFrame": "1 Month"
                },
                {
                    "measure": "Mortality",
                    "description": "Number of days until death",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "RVAD implantation or heart transplant",
                    "description": "Number of days until Right Ventricular Assist Device (RVAD) implantation or heart transplant",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Tricuspid valve surgery or percutaneous tricuspid intervention",
                    "description": "Number of days until tricuspid valve surgery or percutaneous tricuspid intervention",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Heart Failure hospitalization or worsening Heart Failure (HF) which encompasses treatment with IV diuretics in the office or Emergency Department treatment during a <24-hour time period",
                    "description": "Number of days until Heart Failure hospitalization or worsening Heart Failure",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Kansas City Cardiomyopathy Questionnaire (KCCQ) Score",
                    "description": "Change in KCCQ score (score ranges between 0 and 100)",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "New York Heart Association (NYHA class)",
                    "description": "Change in NYHA class (range from I to IV)",
                    "timeFrame": "12 Months"
                },
                {
                    "measure": "Six Minute Walking Test (6MWT)",
                    "description": "Change in walking distance",
                    "timeFrame": "12 Months"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n1. Subject must be 18 years or older, at the time of signing the informed consent.\n2. Subjects has severe tricuspid regurgitation (TR), as determined by the qualifying transthoracic echocardiogram (TTE) confirmed by an echocardiography Core Lab.\n3. NYHA Class III-IVa (not on inotropes, IABP or LVAD) or heart failure (HF) admission in the past 6 months.\n4. Subject is adequately treated with optimal medical therapy (OMT) for heart failure per the local Heart Team for at least 30 days prior to the index procedure, including a diuretic.\n5. The local Heart Team and IEC determine that the patient is eligible for the TricValve procedure.\n6. For females of childbearing potential, negative pregnancy test.\n7. Capable of giving signed informed consent.\n\nExclusion Criteria:\n\n1. Subject had a recent MI, stroke or cardiovascular accident; underwent coronary artery bypass graft surgery, had a percutaneous coronary intervention or other major cardiovascular surgery within 90 days prior to TricValve implantation.\n2. Subject requires another planned major cardiac procedure, including left-sided transcatheter intervention or surgery (e.g. severe aortic stenosis, severe mitral regurgitation), coronary artery bypass or PCI or pulmonary valve correction.\n3. LVEF \u2264 30% on echocardiography.\n4. Evidence of intracardiac, inferior vena cava (IVC), or femoral venous mass, thrombus or vegetation.\n5. Tricuspid stenosis. (Per TVARC, echo criteria: TVA at least 1.5 cm2 or TVAi at least 0.9 cm2/m2 \\[at least 0.75 if BMI \\>30 kg/m2\\], DVI \\<2.2, mean gradient \\<5mm Hg); reduction of total tricuspid regurgitation to optimal (\u2264 mild \\[1+\\]) or acceptable (\u2264 moderate \\[2+\\]).\n6. Severe right ventricular dysfunction.\n7. Cardiac amyloidosis\n8. Pulmonary artery systolic pressure (PASP) \\>65 mmHg assessed with Echo Doppler and /or right heart catheterization.\n9. Lower extremity venous thrombosis and/or the presence of an IVC filter at the time of or 6 months prior to TricValve procedure.\n10. Hemodynamically significant pericardial effusion.\n11. Patient with refractory heart failure requiring advanced intervention (i.e. left ventricular assist device, transplantation) (ACC/ AHA/ ESC/ EACTS Stage D heart failure)\n12. Any known allergy or hypersensitivity to nitinol, bovine tissue or contrast media that cannot be adequately treated with pre-medication.\n13. Unable to tolerate anticoagulation/antiplatelet therapy\n14. Hemodynamic instability, cardiogenic shock, inotropic support, intra-aortic balloon pump or acute heart failure within 30 days prior to the TricValve procedure.\n15. Any known life-threatening condition with an estimated life span of at least 12 months.\n16. Platelet count \\< 75,000/mm3\n17. Child-Pugh Severity Class C (10-15 points).\n18. Severe renal insufficiency with estimated glomerular filtration rate (eGFR) \u2264 25 mL/min/1.73 m2 or requiring chronic renal replacement therapy at the time of enrollment.\n19. Endocarditis or active/ongoing infection requiring antibiotics.\n20. Unable to walk at least 60 meters in a 6minute walk test.\n21. Known bleeding or clotting disorders or patient refuses blood transfusion.\n22. Active gastrointestinal (GI) bleeding within 3 months of randomization.\n23. Presence of significant congenital heart disease including but not limited to hemodynamically significant atrial septal defect, RV dysplasia, and arrhythmogenic RV.\n24. Use or participation in other investigational device or drug study in which patient has not reached a primary endpoint to treat cardiovascular conditions related to the outcomes of the current study.\n25. Any other condition that would preclude ability to meet study requirements in the opinion of the investigator.\n26. Psychiatric/behavioral issues or other medical or social conditions that preclude valid consent and follow-up\n27. Pregnant or breastfeeding subjects and those who plan pregnancy during the clinical investigation follow-up period.",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Monica Tocchi, MD, PhD",
                    "role": "CONTACT",
                    "phone": "9176841700",
                    "email": "m.tocchi@meditrial.net"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Katharina Kiss, MD",
                    "affiliation": "Products & Features GmbH",
                    "role": "STUDY_CHAIR"
                }
            ],
            "locations": [
                {
                    "facility": "St. Joseph's Hospital and Medical Center",
                    "city": "Phoenix",
                    "state": "Arizona",
                    "zip": "85013",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hursh Naik",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 33.44838,
                        "lon": -112.07404
                    }
                },
                {
                    "facility": "Scripps Memorial Hospital La Jolla",
                    "city": "San Diego",
                    "state": "California",
                    "zip": "92037",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Matthew J. Price",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.71533,
                        "lon": -117.15726
                    }
                },
                {
                    "facility": "Tampa General Hospital",
                    "city": "Tampa",
                    "state": "Florida",
                    "zip": "33606",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hiram Bezerra",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 27.94752,
                        "lon": -82.45843
                    }
                },
                {
                    "facility": "Northshore Evanston Hospital",
                    "city": "Evanston",
                    "state": "Illinois",
                    "zip": "60201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mark J. Ricciardi",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.04114,
                        "lon": -87.69006
                    }
                },
                {
                    "facility": "Ascension Medical Group St. Vincent The Heart Center of Indiana",
                    "city": "Indianapolis",
                    "state": "Indiana",
                    "zip": "46260",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "James Hermiller",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.76838,
                        "lon": -86.15804
                    }
                },
                {
                    "facility": "Cardiovascular Institute of the South",
                    "city": "Houma",
                    "state": "Louisiana",
                    "zip": "70360",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Peter Fail",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.59577,
                        "lon": -90.71953
                    }
                },
                {
                    "facility": "Minneapolis Heart Institute Foundation",
                    "city": "Minneapolis",
                    "state": "Minnesota",
                    "zip": "55407",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Paul Sorajja",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 44.97997,
                        "lon": -93.26384
                    }
                },
                {
                    "facility": "Montefiore Medical Center",
                    "city": "Bronx",
                    "state": "New York",
                    "zip": "10467",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Edwin Ho",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.84985,
                        "lon": -73.86641
                    }
                },
                {
                    "facility": "Columbia University Medical Center/ NewYork Presbyterian Hospital",
                    "city": "Irving",
                    "state": "New York",
                    "zip": "10032",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Susheel Kodali",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.56756,
                        "lon": -79.11282
                    }
                },
                {
                    "facility": "Cleveland Clinic",
                    "city": "Cleveland",
                    "state": "Ohio",
                    "zip": "44106",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 41.4995,
                        "lon": -81.69541
                    }
                },
                {
                    "facility": "UPMC Pinnacle",
                    "city": "Harrisburg",
                    "state": "Pennsylvania",
                    "zip": "17107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hemal Gada",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.2737,
                        "lon": -76.88442
                    }
                },
                {
                    "facility": "Houston Methodist",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Neal Kleiman",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "University of Texas (Memorial Hermann)",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Biswajit Kar",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Intermountain Heart Institute - Intermountain Medical Center",
                    "city": "Murray",
                    "state": "Utah",
                    "zip": "84107",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Brian Whisenant",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.66689,
                        "lon": -111.88799
                    }
                },
                {
                    "facility": "MedStar Washington Hospital Center",
                    "city": "Multiple Locations",
                    "state": "Washington",
                    "zip": "20010",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Toby Rogers",
                            "role": "CONTACT"
                        }
                    ]
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "35583363",
                    "type": "BACKGROUND",
                    "citation": "Estevez-Loureiro R, Sanchez-Recalde A, Amat-Santos IJ, Cruz-Gonzalez I, Baz JA, Pascual I, Mascherbauer J, Abdul-Jawad Altisent O, Nombela-Franco L, Pan M, Trillo R, Moreno R, Delle Karth G, Salido-Tahoces L, Santos-Martinez S, Nunez JC, Moris C, Goliasch G, Jimenez-Quevedo P, Ojeda S, Cid-Alvarez B, Santiago-Vacas E, Jimenez-Valero S, Serrador A, Martin-Moreiras J, Strouhal A, Hengstenberg C, Zamorano JL, Puri R, Iniguez-Romo A. 6-Month Outcomes of the TricValve System in Patients With Tricuspid Regurgitation: The TRICUS EURO Study. JACC Cardiovasc Interv. 2022 Jul 11;15(13):1366-1377. doi: 10.1016/j.jcin.2022.05.022. Epub 2022 May 17."
                },
                {
                    "pmid": "37083622",
                    "type": "BACKGROUND",
                    "citation": "Amat-Santos IJ, Estevez-Loureiro R, Sanchez-Recalde A, Cruz-Gonzalez I, Pascual I, Mascherbauer J, Abdul-Jawad Altisent O, Nombela-Franco L, Pan M, Trillo R, Moreno R, Delle Karth G, Blasco-Turrion S, Sanchez-Luna JP, Revilla-Orodoea A, Redondo A, Zamorano JL, Puri R, Iniguez-Romo A, San Roman A. Right heart remodelling after bicaval TricValve implantation in patients with severe tricuspid regurgitation. EuroIntervention. 2023 Aug 7;19(5):e450-e452. doi: 10.4244/EIJ-D-23-00077. No abstract available."
                },
                {
                    "pmid": "35499708",
                    "type": "BACKGROUND",
                    "citation": "Abdul-Jawad Altisent O, Codina P, Puri R, Bayes-Genis A. Transcatheter bi-caval valve implantation (CAVI) significantly improves cardiac output: mechanistic insights following CardioMEMS(R) and TricValve(R) implantation. Clin Res Cardiol. 2022 Aug;111(8):966-968. doi: 10.1007/s00392-022-02029-8. Epub 2022 May 2. No abstract available."
                },
                {
                    "pmid": "37278243",
                    "type": "RESULT",
                    "citation": "Chandran K, Long A, Bishop J, Berman P, Matar F, Oliveira GH, Bezerra HG. First In-Man Experience With TricValve Transcatheter Bicaval Valve System in Left Ventricular Assist Device Heartmate II Patient for High-Risk Tricuspid Regurgitation. Circ Heart Fail. 2023 Jun;16(6):e010027. doi: 10.1161/CIRCHEARTFAILURE.122.010027. Epub 2023 Jun 6. No abstract available."
                }
            ],
            "seeAlsoLinks": [
                {
                    "label": "Description: Products \\& Features, manufacturer of TricValve\u00ae Transcatheter Bicaval Valve System",
                    "url": "https://productsandfeatures.com/"
                },
                {
                    "label": "Meditrial Clinical Research Organization",
                    "url": "http://www.meditrial.net"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "The dataset generated during and/or analysed during the study will be available upon request from the Clinical Research Organization, Meditrial USA Inc. m.tocchi@meditrial.net Datasets will only be made available through publication, unless disclosure is mandated by law.",
            "accessCriteria": "Available on request, Published as a supplement to the results publication."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Australia",
                "Belgium",
                "France",
                "Germany",
                "Spain",
                "Sweden",
                "United Kingdom"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000014262",
                    "term": "Tricuspid Valve Insufficiency"
                }
            ],
            "ancestors": [
                {
                    "id": "D000006349",
                    "term": "Heart Valve Diseases"
                },
                {
                    "id": "D000006331",
                    "term": "Heart Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9421",
                    "name": "Heart Failure",
                    "relevance": "LOW"
                },
                {
                    "id": "M17014",
                    "name": "Tricuspid Valve Insufficiency",
                    "asFound": "Tricuspid Regurgitation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9437",
                    "name": "Heart Valve Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9419",
                    "name": "Heart Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                }
            ]
        },
        "interventionBrowseModule": {
            "browseLeaves": [
                {
                    "id": "T204",
                    "name": "Kava",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "HB",
                    "name": "Herbal and Botanical"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}